source
- Novartis announces new North Carolina manufacturing plant, completing its $23 billion U.S. expansionNovartis disclosed plans to construct another manufacturing facility in the United States, adding to its ongoing expansion program. The new plant will be located in North Carolina and represents t…
- Avalyn Pharma raises $300M in IPO to fund inhalable lung-fibrosis drugsAvalyn Pharma completed a $300 million initial public offering, pricing 16.7 million shares at $18 each and exceeding its original $200 million target. The proceeds will be used to develop inhalab…